Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Schiff

Showing results (81-90 of 199) with videos related to

Pageof 20
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2007
Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancerLakshmi Sampath, Sunkuk Kwon, Shi Ke, et al.
Nature Reviews. Clinical Oncology|December 15, 2019
Towards personalized treatment for early stage HER2-positive breast cancerKristina Goutsouliak, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2019
The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cellsYuan Yin, Chuan-Ming Xie, Hua Li, et al.
Oncogene|March 1, 2005
Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cellsSanaa M Nabha, Selina Glaros, Meng Hong, et al.
NPJ Breast Cancer|November 24, 2017
PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cellsKoichi Ito, Sun Hee Park, Igor Katsyv, et al.
Journal of the National Cancer Institute|September 8, 2005
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistanceGrazia Arpino, Heidi Weiss, Adrian V Lee, et al.
Breast Cancer Research and Treatment|March 11, 2010
Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cellsLaura B Carpin, Lissett R Bickford, Germaine Agollah, et al.
Cancer Research|October 3, 2008
Dual roles for coactivator activator and its counterbalancing isoform coactivator modulator in human kidney cell tumorigenesisYun Kyoung Kang, Rachel Schiff, Lan Ko, et al.
Breast Cancer Research : BCR|August 11, 2020
Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistanceLi Li, Ling Lin, Jamunarani Veeraraghavan, et al.
Cancer Research|August 17, 2006
Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancerSuleiman Massarweh, C Kent Osborne, Shou Jiang, et al.
Pageof 20

Showing results (81-90 of 199) with videos related to

Sort By:
Pageof 20
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2007
Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancerLakshmi Sampath, Sunkuk Kwon, Shi Ke, et al.
Nature Reviews. Clinical Oncology|December 15, 2019
Towards personalized treatment for early stage HER2-positive breast cancerKristina Goutsouliak, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2019
The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cellsYuan Yin, Chuan-Ming Xie, Hua Li, et al.
Oncogene|March 1, 2005
Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cellsSanaa M Nabha, Selina Glaros, Meng Hong, et al.
NPJ Breast Cancer|November 24, 2017
PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cellsKoichi Ito, Sun Hee Park, Igor Katsyv, et al.
Journal of the National Cancer Institute|September 8, 2005
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistanceGrazia Arpino, Heidi Weiss, Adrian V Lee, et al.
Breast Cancer Research and Treatment|March 11, 2010
Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cellsLaura B Carpin, Lissett R Bickford, Germaine Agollah, et al.
Cancer Research|October 3, 2008
Dual roles for coactivator activator and its counterbalancing isoform coactivator modulator in human kidney cell tumorigenesisYun Kyoung Kang, Rachel Schiff, Lan Ko, et al.
Breast Cancer Research : BCR|August 11, 2020
Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistanceLi Li, Ling Lin, Jamunarani Veeraraghavan, et al.
Cancer Research|August 17, 2006
Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancerSuleiman Massarweh, C Kent Osborne, Shou Jiang, et al.
Pageof 20